2,075 Shares in Colgate-Palmolive (NYSE:CL) Purchased by TFB Advisors LLC

TFB Advisors LLC bought a new stake in Colgate-Palmolive (NYSE:CL) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,075 shares of the company’s stock, valued at approximately $201,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of CL. Adero Partners LLC grew its holdings in shares of Colgate-Palmolive by 14.0% during the second quarter. Adero Partners LLC now owns 2,866 shares of the company’s stock worth $278,000 after buying an additional 352 shares in the last quarter. International Assets Investment Management LLC lifted its stake in shares of Colgate-Palmolive by 5.4% during the 2nd quarter. International Assets Investment Management LLC now owns 3,141 shares of the company’s stock worth $305,000 after purchasing an additional 162 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd grew its position in shares of Colgate-Palmolive by 1.3% in the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 93,564 shares of the company’s stock valued at $9,079,000 after purchasing an additional 1,192 shares during the period. Signaturefd LLC increased its stake in Colgate-Palmolive by 26.5% in the second quarter. Signaturefd LLC now owns 17,705 shares of the company’s stock valued at $1,718,000 after purchasing an additional 3,711 shares during the last quarter. Finally, Arjuna Capital boosted its stake in Colgate-Palmolive by 0.8% in the 2nd quarter. Arjuna Capital now owns 38,004 shares of the company’s stock worth $3,688,000 after buying an additional 314 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, insider Panagiotis Tsourapas sold 14,794 shares of the company’s stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the completion of the transaction, the insider now directly owns 5,146 shares in the company, valued at approximately $529,729.24. The sale was disclosed in a document filed with the SEC, which is available through this link. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Panagiotis Tsourapas sold 14,794 shares of the firm’s stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the transaction, the insider now directly owns 5,146 shares in the company, valued at $529,729.24. The disclosure for this sale can be found here. Insiders have sold 43,490 shares of company stock valued at $4,486,063 over the last quarter. Insiders own 0.34% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the topic of several recent analyst reports. Sanford C. Bernstein increased their price objective on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a report on Tuesday, July 30th. Wells Fargo & Company lifted their price target on shares of Colgate-Palmolive from $92.00 to $97.00 and gave the company an “equal weight” rating in a report on Wednesday, July 10th. Evercore ISI upped their price objective on Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a report on Thursday, July 18th. Jefferies Financial Group lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their target price for the stock from $103.00 to $95.00 in a research report on Wednesday, July 24th. Finally, TD Cowen boosted their price target on Colgate-Palmolive from $110.00 to $115.00 and gave the company a “buy” rating in a research report on Tuesday, July 30th. Eight investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average target price of $101.11.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $106.50 on Friday. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.28 and a current ratio of 1.06. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $106.72. The firm’s 50-day simple moving average is $99.92 and its 200-day simple moving average is $93.45. The firm has a market cap of $87.38 billion, a PE ratio of 33.70, a price-to-earnings-growth ratio of 3.54 and a beta of 0.39.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The business had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. During the same period in the previous year, the business earned $0.77 EPS. The business’s quarterly revenue was up 4.9% on a year-over-year basis. Equities analysts forecast that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were paid a dividend of $0.50 per share. The ex-dividend date was Friday, July 19th. This represents a $2.00 annualized dividend and a yield of 1.88%. Colgate-Palmolive’s dividend payout ratio (DPR) is 63.29%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.